World Lung Cancer Day 2023: Disease’s symptoms, diagnosis, and treatments
“The annual commemoration has raised awareness for lung cancer for more than a decade”

Study Identifies Which Patients With SCLC May Benefit Most From SRS
“A retrospective review published in the journal Advances in Radiation Oncology suggests that patients with small cell lung cancer (SCLC) who have fewer than 5 brain metastases may benefit more from stereotactic radiosurgery (SRS) than patients with more than 5 brain metastases.”

Capito cosponsors Women and Lung Cancer Research and Preventive Services Act
“U.S. Sen. Shelley Moore Capito (R-WV) on Tuesday proposed bipartisan legislation that aims to promote more research into preventing and managing lung cancer among women who are non-smokers.”

Lung Cancer Patients Hospitalized With irAEs Due to ICIs Have Shorter Survival
“Lung cancer patients who have immune-related adverse events (irAEs) when treated with immune checkpoint inhibitors (ICIs) have worse survival outcomes than patients with other cancers who have irAEs on ICI treatment, according to a study published in The Oncologist.”

Prediction of Lung Cancer Mortality With Blood-Based Biomarker Panel and PLCO Risk Model
“In a study reported in the Journal of Clinical Oncology, Irajizad et al found that use of a blood-based four-marker protein panel (4MP)—together with the Prostate, Lung, Colorectal, and Ovarian (PLCOm2012) lung cancer risk model—was capable of identifying patients at high risk of lung cancer mortality.”

Protein Uncovered Implicated in Lung Cancer Resistance to TKIs
“A new study from researchers at the Mass General Cancer Center has uncovered a protein that is implicated in lung cancer resistance to tyrosine kinase inhibitor (TKI) therapies. The research, published Wednesday in Nature suggest the protein, APOBEC3A, could be a promising target for therapeutic development.”